Skip to Main Content

Paper Details

Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
Cold Spring Harb Mol Case Stud
5
2022
L1, PD-, PD-1, PD-L1, SUC, Sarcomatoid urothelial carcinoma, UC, anti-PD1, immune cell repertoire, metastatic sarcomatoid urothelial carcinoma, patient, platinum, programmed cell death 1 protein, urothelial carcinoma
Author NameAffiliation
Kentaro Ohara
Kentaro OharaCaryl and Israel Englander Institute for Precision Medicine
Noah GrecoCaryl and Israel Englander Institute for Precision Medicine
Michael SigourosCaryl and Israel Englander Institute for Precision Medicine
Samuel V AngiuoliInc.
Bishoy M FaltasCaryl and Israel Englander Institute for Precision Medicine
Bishoy M Faltas
Cora N SternbergCaryl and Israel Englander Institute for Precision Medicine
Cora N Sternberg
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine
Olivier ElementoInstitute for Computational Biomedicine
Olivier Elemento
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine
Olivier Elemento
Olivier ElementoInstitute for Computational Biomedicine
Juan Miguel Mosquera
Juan Miguel MosqueraCaryl and Israel Englander Institute for Precision Medicine
Juan Miguel Mosquera
Juan Miguel MosqueraCaryl and Israel Englander Institute for Precision Medicine
  • 1 - 19

Datasets

Release 1.2